Gendx Is A Molecular Diagnostics Company Based In The Netherlandsspecializing In Transplant Diagnostics And Personalized Healthcare Solutionsfounded In 2005The Company Operates From Utrecht Science Park And Was Acquired By Eurobio Scientific In August 2022Gendx Focuses On High Resolution Hla Typing And Related Services To Enhance Transplantation Outcomes And Patient Care The Company Offers A Range Of Servicesincluding High Resolution Hla Typing For Transplant Compatibility Testingchimerism Monitoring To Assess Donor Recipient Cell Ratiosand Next Generation Sequencingngskir Typinggendx Also Provides Custom Lab Services Tailored For Research And Clinical Applicationswith Over 15 Years Of Expertise In Hla And Transplant Related Testinggendx Is Committed To Innovationincluding Proprietary Amplification Technologies That Improve Dna Analysis Efficiency
